×
ADVERTISEMENT

HCV

Senators Introduce Bill Aimed to Support Fight to Cure Hep C

A new bill introduced to the U.S. Senate aims to increase funding and access for hepatitis C virus treatment in the ...

JUNE 5, 2025

Pharmacists Combat Rising Hepatitis C Rates

Data presented at the ASHP Midyear 2024 Clinical Meeting & Exhibition outline how pharmacist-led programs can ...

JANUARY 23, 2025

SP Pharmacist–Led ED Program Boosts Hepatitis C Treatment

An emergency department-focused, specialty pharmacist–led program for management of HCV at the University of ...

OCTOBER 25, 2024

Pharmacists Help Build a Model HCV Clinic

A pharmacist-led clinic in Washington offers a model for how community pharmacies can address hepatitis C virus ...

AUGUST 31, 2023

Disappointing Results for U.S. Hepatitis Clearance Cascade

There are more than 2 million people living with hepatitis C, a silent killer, in the United States.

AUGUST 10, 2023

Most Americans With HCV Not Receiving DAAs

More than 2 million people in the United States have HCV, and most of them have not received direct-acting ...

AUGUST 8, 2023

Most Americans With HCV Not Receiving DAAs

More than 2 million people in the United States have hepatitis C virus, and most of them have not received ...

JUNE 30, 2023

Pharmacist-Led Clinic Combats Hepatitis C

A pharmacist-led clinic in Washington offers a model for how community pharmacies can address hepatitis C virus ...

MARCH 29, 2023

Direct-Acting Antivirals, an Effective Treatment for HCV

Treating patients with chronic HCV with direct-acting antivirals is associated with improved liver and non-liver ...

MARCH 7, 2023

Data Mining Project is an Epic Victory for Vanderbilt’s Specialty HCV Clinic

Vanderbilt specialty pharmacists are using an overlooked reporting tool in Epic to streamline data reporting in its ...

SEPTEMBER 22, 2022

Software Program Streamlines HCV Rx Access

COVID-19 forced the HCV prior authorization team at the University of Illinois Hospital and Health Sciences System ...

MARCH 7, 2022

Combo Therapy Opens Door to HCV+ Organ Transplants

Combination therapy with direct-acting antivirals (DAAs) and ezetimibe is effective at preventing or rapidly curing ...

MARCH 9, 2020

Load more